IP Library Granted Patent US 8,436,014
Granted Patent B2
US 8,436,014 · App. 12/605,266 · Granted May 7, 2013

Solid forms of N-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluorormethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihyroquinoline-3-carboxamide

Inventors: Beili Zhang (San Diego, CA); Mariusz Krawiec (Marlborough, MA); Martyn Botfield (Concord, MA); Peter D. J. Grootenhuis (San Diego, CA); Fredrick Van Goor (San Diego, CA)
Assignee: Vertex Pharmaceutical Incorporated
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,436,014
App. No.
12/605,266
Granted
May 7, 2013
Kind
B2
Abstract

The present invention relates to solid state forms, for example, crystalline forms of N-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide, pharmaceutical compositions thereof, and methods therewith.

Claims (13)

1. A Crystalline N-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide characterized as Form A, wherein the Form A is characterized by a peak at about 7.9 degrees, and a peak at about 11.9 degrees in an X-ray powder diffraction pattern.

2. Form A of claim 1 , wherein the Form A is further characterized by a peak at about 9.3 degrees in an X-ray powder diffraction pattern.

3. Form A of claim 1 , wherein the Form A is further characterized by a peak at about 14.4 degrees in an X-ray powder diffraction pattern.

4. Form A of claim 3 , wherein the Form A is further characterized by a peak at about 15.8 degrees in an X-ray powder diffraction pattern.

5. Form A of claim 1 , wherein the Form A is further characterized by a peak at about 19.3 degrees in an X-ray powder diffraction pattern.

6. Form A of claim 4 , wherein the Form A is further characterized by a peak at about 21.8 degrees in an X-ray powder diffraction pattern.

7. Form A of claim 6 , wherein the Form A is further characterized by a peak at about 23.8 degrees in an X-ray powder diffraction pattern.

8. Form A of claim 1 , wherein the Form A is further characterized by a peak at about 14.4 degrees, and a peak at about 15.8 degrees in an X-ray powder diffraction pattern.

9. Form A of claim 1 , wherein the Form A is further characterized by a diffraction pattern shown to that of FIG. 1 .

10. Form A of claim 8 , wherein the Form A is characterized by a peak at about 9.3 degrees, a peak at about 19.3 degrees, a peak at about 21.8 degrees and a peak at about 23.8 degrees.

11. Form A of claim 7 , wherein the Form A is further characterized by a peak at about 15.1 degrees in an X-ray powder diffraction pattern, a peak at about 17.0 degrees in an X-ray powder diffraction pattern, a peak at about 17.7 degrees in an X-ray powder diffraction pattern, a peak at about 21.4 degrees in an X-ray powder diffraction pattern, a peak at about 23.4 degrees in an X-ray powder diffraction pattern.

12. Form A of claim 11 , wherein the Form A is further characterized by a peak at about 25.6 degrees, a peak at about 26.8 degrees, a peak at about 29.4 degrees, a peak at about 29.7 degrees, a peak at about 30.1 degrees and a peak at about 31.2 degrees in an X-ray powder diffraction pattern.

13. Form A of claim 7 , wherein the Form A is further characterized by a peak at about 25.6 degrees, a peak at about 26.8 degrees, a peak at about 29.4 degrees, a peak at about 29.7 degrees, a peak at about 30.1 degrees and a peak at about 31.2 degrees in an X-ray powder diffraction pattern.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Oct 14, 2016
From: MACQUARIE US TRADING LLC
To: VERTEX PHARMACEUTICALS INCORPORATED; VERTEX PHARMACEUTICALS (SAN DIEGO) LLC
Reel/Frame 040357/0001 →
ASSIGNEE CHANGE OF ADDRESS Recorded Feb 12, 2016
From: VERTEX PHARMACEUTICALS INCORPORATED
To: VERTEX PHARMACEUTICALS INCORPORATED
Reel/Frame 037810/0283 →
SECURITY INTEREST Recorded Jul 10, 2014
From: VERTEX PHARMACEUTICALS INCORPORATED; VERTEX PHARMACEUTICALS (SAN DIEGO) LLC
To: MACQUARIE US TRADING LLC
Reel/Frame 033292/0311 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 28, 2010
From: ZHANG, BEILI; KRAWIEC, MARIUSZ; BOTFIELD, MARTYN; GROOTENHUIS, PETER D.J.; VAN GOOR, FREDRICK
To: VERTEX PHARMACEUTICALS INCORPORATED
Reel/Frame 023862/0592 →
Continuity (2)
Provisional Application 61107813 · Oct 23, 2008
Related Publication 20100130547A1 · May 27, 2010